Strategy Expands Screening for
Bacterial Effectors Key to Plant Diseases
 |
| Arabidopsis thaliana,
a small annual weed which is proving to be valuable for rapid
genetic and molecular analysis, including identifying genes that
encode potential effector proteins in pathogens. (Scanning
electron micrograph courtesy of Thomas Laux and Jurgen Berger,
Max-Planck-Institute/Science Photo Library.) |
Researchers at the University of Toronto (UT) and
University of Chicago (UC) recently developed a means for identifying
genes whose products enable certain bacteria to infect specific types of
plants. This functional screening method, which is based on monitoring
responses of Arabidopsis thaliana to putative effector
proteins from plant pathogens, could yield insights that would enable
researchers to control bacterial infections in crops and other
economically important plants, and might also prove applicable to
infectious diseases in humans.
David Guttman and his colleagues at the UT in Toronto,
Ontario, Canada, and their collaborators at UC in Chicago, Ill., are
studying several proteins in Pseudomonas syringae, a
gram-negative plant pathogen, that make up the type III secretion system
of that bacterium. These type III secretion proteins, whose close
relatives are found among many other gram-negative bacteria, enable
other proteins, known as effectors, to enter cells of host plantsas
if "the type III secretion apparatus is the syringe while the type
III effectors are the drugs," he says.
Highly varied effector proteins are found in other
bacteria, including P. syringae and other plant pathogens such as
Xanthomonas campestris, as well as among other pathogens that
infect animals, including humans. The effector proteins from plant
pathogens are responsible for damaging infected plant hosts, explaining
why researchers are seeking to identify such effectors and find means to
block their sometimes devastating effects.
However, Guttman says, "Up until now, there hasn't
been a direct system for looking at the genes used in the natural
interaction between a bacterium and its host." Moreover,
identifying genes that encode potential effector proteins is difficult
with traditional mutational analyses. Typically, a phenotype resulting
from mutations in a single effector gene can be so slight as to be
indistinguishable from the wild type, according to Jim Alfano of the
University of Nebraska, Lincoln, Neb., who also is studying plant
pathogens.
The functional screen devised by Guttman is based on
measuring responses by a relatively simple plant, Arabidopsis thaliana,
to potential effector proteins. The technique relies on hooking a region
of a gene that codes for the functional portion of a known effector to a
region in a candidate effector that is suspected of being a type III
secretion signal. "The secretion signal from the unknown effector
could then move the effector domain of the known effector into the plant
cell," says Guttman, in which case the plant will mount a
hypersensitive response against the combined material.
To test this screening procedure, a portion of gene of a
known effector gene minus its type III secretion signal was inserted
randomly into many different sites of the genome of P. syringae,
including into genes encoding unidentified effectors, which themselves
contain secretion signals. When the effector gene attaches to these
secretion gene signals, the fused genes become detectable when bacteria
containing them are injected into A. thaliana plants. The
detected candidate effectors are then traced within the genome, and
their genes identified. Additional details of the screening method are
described in a report published recently in Science (295:1722-1726,
March 1, 2002).
In one series of experiments, 25 hypersensitive plants
led Guttman to identify 13 new effectors. Computer analysis conducted
with colleagues at the University of Chicago expanded the number of
possible type III effectors in P. syringae to 38, more than
double the number of previously known bacterial plant effectors.
"[Guttman and colleagues] have designed a very
clever screen to identify just the proteins that are transferred from a
pathogen to its host via the type III secretion system[which] will be
very useful to researchers using the P. syringae bacterial genome
sequence," says Sarah Grant of the University of North Carolina at
Chapel Hill, who is also studying P. syringae pathogenicity
factors. "This paper increases the inventory of possible effectors,
which is quite important," Alfano says, noting that some of the
proteins identified through such screens may not be bona fide effectors
but could have supporting roles in pathogenesis.
"When we understand how these natural interactions
work, we can control the bacteria either by traditional plant breeding
methods or by engineering plants to resist the bacteria," Guttman
says. Grant agrees with this outlook, noting that "the effectors
will lead us to a variety of host proteins with which they interact to
cause disease. The plant proteins that are the targets of conserved
effectors might be logical starting points to mutate or genetically
engineer in order to get disease-resistant plants."
Guttman hopes to use the functional screen to learn how
certain bacterial strains survive on some hosts but not others. "In
the long term, we may be able to extend this research to identify
elements of bacterial pathogens of animals such as Salmonella or E.
coli," he says. "The new screening process has opened up a
tremendous pool of resources to study and understand the whole process
of pathogenesis."
Brian Hoyle
Brian Hoyle is President of Square Rainbow Limited, a science
writing and editing company located in Bedford, Nova Scotia, Canada.